European Molecular Diagnostics in Cancer Testing Industry 2016 Market Research Report
The European Molecular Diagnostics in Cancer Testing Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Molecular Diagnostics in Cancer Testing industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Molecular Diagnostics in Cancer Testing market analysis is provided for the European markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on European major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Molecular Diagnostics in Cancer Testing industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 153 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Molecular Diagnostics in Cancer Testing market analysis is provided for the European markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on European major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Molecular Diagnostics in Cancer Testing industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 153 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 INDUSTRY OVERVIEW
1.1 Definition and Specifications of Molecular Diagnostics in Cancer Testing
1.2 Classification of Molecular Diagnostics in Cancer Testing
1.3 Applications of Molecular Diagnostics in Cancer Testing
1.4 Industry Chain Structure of Molecular Diagnostics in Cancer Testing
1.5 Industry Overview of Molecular Diagnostics in Cancer Testing
1.6 Industry Policy Analysis of Molecular Diagnostics in Cancer Testing
1.7 Industry News Analysis of Molecular Diagnostics in Cancer Testing
2 MANUFACTURING COST STRUCTURE ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING
2.1 Bill of Materials (BOM) of Molecular Diagnostics in Cancer Testing
2.2 BOM Price Analysis of Molecular Diagnostics in Cancer Testing
2.3 Labor Cost Analysis of Molecular Diagnostics in Cancer Testing
2.4 Depreciation Cost Analysis of Molecular Diagnostics in Cancer Testing
2.5 Manufacturing Cost Structure Analysis of Molecular Diagnostics in Cancer Testing
2.6 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
2.7 European Price, Cost and Gross of Molecular Diagnostics in Cancer Testing 2011-2016
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS
3.1 Capacity and Commercial Production Date of European Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of European Key Molecular Diagnostics in Cancer Testing Manufacturers in 2015
3.3 R&D Status and Technology Source of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
4 PRODUCTION ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING BY REGIONS, TYPE, AND APPLICATIONS
4.1 European Production of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
4.2 European Production of Molecular Diagnostics in Cancer Testing by Type 2011-2016
4.3 European Sales of Molecular Diagnostics in Cancer Testing by Applications 2011-2016
4.4 Price Analysis of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
4.5 European Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Molecular Diagnostics in Cancer Testing 2011-2016
5 CONSUMPTION VOLUME AND CONSUMPTION VALUE ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING BY REGIONS
5.1 European Consumption Volume of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
5.2 European Consumption Value of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
5.3 European Consumption Price Analysis of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
6 ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Molecular Diagnostics in Cancer Testing 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Molecular Diagnostics in Cancer Testing 2014-2015
6.3 Sales Overview of Molecular Diagnostics in Cancer Testing 2011-2016
6.4 Supply, Consumption and Gap of Molecular Diagnostics in Cancer Testing 2011-2016
6.5 Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Molecular Diagnostics in Cancer Testing 2011-2016
7 ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING INDUSTRY KEY MANUFACTURERS
7.1 Abbott Molecular Diagnostics
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott Molecular Diagnostics SWOT Analysis
7.2 Accugenomics, Inc.
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Accugenomics, Inc. SWOT Analysis
7.3 Agendia
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Agendia SWOT Analysis
7.4 Ambry Genetics
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Ambry Genetics SWOT Analysis
7.5 Biodesix
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Biodesix SWOT Analysis
7.6 bioMerieux
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 bioMerieux SWOT Analysis
7.7 bioTheranostics (AviaraDx)
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 bioTheranostics (AviaraDx) SWOT Analysis
7.8 Cancer Genetics, Inc.
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Cancer Genetics, Inc. SWOT Analysis
7.9 Clarient, Inc. (GE Healthcare)
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Clarient, Inc. (GE Healthcare) SWOT Analysis
7.10 Counsyl
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Counsyl SWOT Analysis
7.11 Flatiron Health
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Flatiron Health SWOT Analysis
7.12 Epigenomics
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Epigenomics SWOT Analysis
7.13 Exact Sciences Corporation
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Exact Sciences Corporation SWOT Analysis
7.14 Exiqon
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Exiqon SWOT Analysis
7.15 Genomic Health, Inc.
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Genomic Health, Inc. SWOT Analysis
7.16 Genoptix, Inc. (Novartis)
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Genoptix, Inc. (Novartis) SWOT Analysis
7.17 Genmark Diagnostics
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Genmark Diagnostics SWOT Analysis
7.18 Genomictree
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Genomictree SWOT Analysis
7.19 HTG Molecular Diagnostics
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 HTG Molecular Diagnostics SWOT Analysis
7.20 Invitae
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Invitae SWOT Analysis
7.21 LabCorp
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 LabCorp SWOT Analysis
7.22 Myriad Genetics, Inc.
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Myriad Genetics, Inc. SWOT Analysis
7.23 Nanostring
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Nanostring SWOT Analysis
7.24 Neogenomics
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Neogenomics SWOT Analysis
7.25 NSTG
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 NSTG SWOT Analysis
7.26 Nuvera Biosciences
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Nuvera Biosciences SWOT Analysis
7.27 Orion Genomics
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Orion Genomics SWOT Analysis
7.28 Pathway Genomics
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 Pathway Genomics SWOT Analysis
7.29 Personal Genome Diagnostics
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Personal Genome Diagnostics SWOT Analysis
7.30 Quest Diagnostics
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Quest Diagnostics SWOT Analysis
7.31 Rosetta Genomics Ltd.
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 Rosetta Genomics Ltd. SWOT Analysis
7.32 Signal Genetics
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.32.4 Signal Genetics SWOT Analysis
7.33 Source MDx
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.33.4 Source MDx SWOT Analysis
7.34 Wilex, Inc.
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.34.4 Wilex, Inc. SWOT Analysis
8 PRICE AND GROSS MARGIN ANALYSIS
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Molecular Diagnostics in Cancer Testing Product Types
8.5 Market Share Analysis of Different Molecular Diagnostics in Cancer Testing Price Levels
8.6 Gross Margin Analysis of Different Molecular Diagnostics in Cancer Testing Applications
9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING
9.1 Marketing Channels Status of Molecular Diagnostics in Cancer Testing
9.2 Traders or Distributors of Molecular Diagnostics in Cancer Testing with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Molecular Diagnostics in Cancer Testing
9.4 European Import, Export and Trade Analysis of Molecular Diagnostics in Cancer Testing
10 DEVELOPMENT TREND OF MOLECULAR DIAGNOSTICS IN CANCER TESTING INDUSTRY 2016-2021
10.1 Capacity and Production Overview of Molecular Diagnostics in Cancer Testing 2016-2021
10.2 Production Market Share by Product Types of Molecular Diagnostics in Cancer Testing 2016-2021
10.3 Sales and Sales Revenue Overview of Molecular Diagnostics in Cancer Testing 2016-2021
10.4 European Sales of Molecular Diagnostics in Cancer Testing by Applications 2016-2021
10.5 Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Molecular Diagnostics in Cancer Testing 2016-2021
11 INDUSTRY CHAIN SUPPLIERS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING WITH CONTACT INFORMATION
11.1 Major Raw Materials Suppliers of Molecular Diagnostics in Cancer Testing with Contact Information
11.2 Manufacturing Equipment Suppliers of Molecular Diagnostics in Cancer Testing with Contact Information
11.3 Major Players of Molecular Diagnostics in Cancer Testing with Contact Information
11.4 Key Consumers of Molecular Diagnostics in Cancer Testing with Contact Information
11.5 Supply Chain Relationship Analysis of Molecular Diagnostics in Cancer Testing
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING
12.1 New Project SWOT Analysis of Molecular Diagnostics in Cancer Testing
12.2 New Project Investment Feasibility Analysis of Molecular Diagnostics in Cancer Testing
13 CONCLUSION OF THE EUROPEAN MOLECULAR DIAGNOSTICS IN CANCER TESTING INDUSTRY 2016 MARKET RESEARCH REPORT
1.1 Definition and Specifications of Molecular Diagnostics in Cancer Testing
1.2 Classification of Molecular Diagnostics in Cancer Testing
1.3 Applications of Molecular Diagnostics in Cancer Testing
1.4 Industry Chain Structure of Molecular Diagnostics in Cancer Testing
1.5 Industry Overview of Molecular Diagnostics in Cancer Testing
1.6 Industry Policy Analysis of Molecular Diagnostics in Cancer Testing
1.7 Industry News Analysis of Molecular Diagnostics in Cancer Testing
2 MANUFACTURING COST STRUCTURE ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING
2.1 Bill of Materials (BOM) of Molecular Diagnostics in Cancer Testing
2.2 BOM Price Analysis of Molecular Diagnostics in Cancer Testing
2.3 Labor Cost Analysis of Molecular Diagnostics in Cancer Testing
2.4 Depreciation Cost Analysis of Molecular Diagnostics in Cancer Testing
2.5 Manufacturing Cost Structure Analysis of Molecular Diagnostics in Cancer Testing
2.6 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
2.7 European Price, Cost and Gross of Molecular Diagnostics in Cancer Testing 2011-2016
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS
3.1 Capacity and Commercial Production Date of European Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of European Key Molecular Diagnostics in Cancer Testing Manufacturers in 2015
3.3 R&D Status and Technology Source of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
4 PRODUCTION ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING BY REGIONS, TYPE, AND APPLICATIONS
4.1 European Production of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
4.2 European Production of Molecular Diagnostics in Cancer Testing by Type 2011-2016
4.3 European Sales of Molecular Diagnostics in Cancer Testing by Applications 2011-2016
4.4 Price Analysis of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
4.5 European Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Molecular Diagnostics in Cancer Testing 2011-2016
5 CONSUMPTION VOLUME AND CONSUMPTION VALUE ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING BY REGIONS
5.1 European Consumption Volume of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
5.2 European Consumption Value of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
5.3 European Consumption Price Analysis of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
6 ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING PRODUCTION, SUPPLY, SALES AND MARKET STATUS 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Molecular Diagnostics in Cancer Testing 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Molecular Diagnostics in Cancer Testing 2014-2015
6.3 Sales Overview of Molecular Diagnostics in Cancer Testing 2011-2016
6.4 Supply, Consumption and Gap of Molecular Diagnostics in Cancer Testing 2011-2016
6.5 Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Molecular Diagnostics in Cancer Testing 2011-2016
7 ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING INDUSTRY KEY MANUFACTURERS
7.1 Abbott Molecular Diagnostics
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott Molecular Diagnostics SWOT Analysis
7.2 Accugenomics, Inc.
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Accugenomics, Inc. SWOT Analysis
7.3 Agendia
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Agendia SWOT Analysis
7.4 Ambry Genetics
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Ambry Genetics SWOT Analysis
7.5 Biodesix
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Biodesix SWOT Analysis
7.6 bioMerieux
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 bioMerieux SWOT Analysis
7.7 bioTheranostics (AviaraDx)
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 bioTheranostics (AviaraDx) SWOT Analysis
7.8 Cancer Genetics, Inc.
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Cancer Genetics, Inc. SWOT Analysis
7.9 Clarient, Inc. (GE Healthcare)
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Clarient, Inc. (GE Healthcare) SWOT Analysis
7.10 Counsyl
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Counsyl SWOT Analysis
7.11 Flatiron Health
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Flatiron Health SWOT Analysis
7.12 Epigenomics
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Epigenomics SWOT Analysis
7.13 Exact Sciences Corporation
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Exact Sciences Corporation SWOT Analysis
7.14 Exiqon
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Exiqon SWOT Analysis
7.15 Genomic Health, Inc.
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Genomic Health, Inc. SWOT Analysis
7.16 Genoptix, Inc. (Novartis)
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Genoptix, Inc. (Novartis) SWOT Analysis
7.17 Genmark Diagnostics
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Genmark Diagnostics SWOT Analysis
7.18 Genomictree
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Genomictree SWOT Analysis
7.19 HTG Molecular Diagnostics
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 HTG Molecular Diagnostics SWOT Analysis
7.20 Invitae
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Invitae SWOT Analysis
7.21 LabCorp
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 LabCorp SWOT Analysis
7.22 Myriad Genetics, Inc.
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Myriad Genetics, Inc. SWOT Analysis
7.23 Nanostring
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Nanostring SWOT Analysis
7.24 Neogenomics
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.24.4 Neogenomics SWOT Analysis
7.25 NSTG
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.25.4 NSTG SWOT Analysis
7.26 Nuvera Biosciences
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.26.4 Nuvera Biosciences SWOT Analysis
7.27 Orion Genomics
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.27.4 Orion Genomics SWOT Analysis
7.28 Pathway Genomics
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.28.4 Pathway Genomics SWOT Analysis
7.29 Personal Genome Diagnostics
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.29.4 Personal Genome Diagnostics SWOT Analysis
7.30 Quest Diagnostics
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.30.4 Quest Diagnostics SWOT Analysis
7.31 Rosetta Genomics Ltd.
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.31.4 Rosetta Genomics Ltd. SWOT Analysis
7.32 Signal Genetics
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.32.4 Signal Genetics SWOT Analysis
7.33 Source MDx
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.33.4 Source MDx SWOT Analysis
7.34 Wilex, Inc.
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.34.4 Wilex, Inc. SWOT Analysis
8 PRICE AND GROSS MARGIN ANALYSIS
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Molecular Diagnostics in Cancer Testing Product Types
8.5 Market Share Analysis of Different Molecular Diagnostics in Cancer Testing Price Levels
8.6 Gross Margin Analysis of Different Molecular Diagnostics in Cancer Testing Applications
9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING
9.1 Marketing Channels Status of Molecular Diagnostics in Cancer Testing
9.2 Traders or Distributors of Molecular Diagnostics in Cancer Testing with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Molecular Diagnostics in Cancer Testing
9.4 European Import, Export and Trade Analysis of Molecular Diagnostics in Cancer Testing
10 DEVELOPMENT TREND OF MOLECULAR DIAGNOSTICS IN CANCER TESTING INDUSTRY 2016-2021
10.1 Capacity and Production Overview of Molecular Diagnostics in Cancer Testing 2016-2021
10.2 Production Market Share by Product Types of Molecular Diagnostics in Cancer Testing 2016-2021
10.3 Sales and Sales Revenue Overview of Molecular Diagnostics in Cancer Testing 2016-2021
10.4 European Sales of Molecular Diagnostics in Cancer Testing by Applications 2016-2021
10.5 Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Molecular Diagnostics in Cancer Testing 2016-2021
11 INDUSTRY CHAIN SUPPLIERS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING WITH CONTACT INFORMATION
11.1 Major Raw Materials Suppliers of Molecular Diagnostics in Cancer Testing with Contact Information
11.2 Manufacturing Equipment Suppliers of Molecular Diagnostics in Cancer Testing with Contact Information
11.3 Major Players of Molecular Diagnostics in Cancer Testing with Contact Information
11.4 Key Consumers of Molecular Diagnostics in Cancer Testing with Contact Information
11.5 Supply Chain Relationship Analysis of Molecular Diagnostics in Cancer Testing
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF MOLECULAR DIAGNOSTICS IN CANCER TESTING
12.1 New Project SWOT Analysis of Molecular Diagnostics in Cancer Testing
12.2 New Project Investment Feasibility Analysis of Molecular Diagnostics in Cancer Testing
13 CONCLUSION OF THE EUROPEAN MOLECULAR DIAGNOSTICS IN CANCER TESTING INDUSTRY 2016 MARKET RESEARCH REPORT
LIST OF TABLES AND FIGURES
Figure Picture of Molecular Diagnostics in Cancer Testing
Table Product Specifications of Molecular Diagnostics in Cancer Testing
Table Classification of Molecular Diagnostics in Cancer Testing
Figure European Sales Market Share of Molecular Diagnostics in Cancer Testing by Product Types in 2015
Table Applications of Molecular Diagnostics in Cancer Testing
Figure European Sales Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2015
Figure Industry Chain Structure of Molecular Diagnostics in Cancer Testing
Table European Industry Overview of Molecular Diagnostics in Cancer Testing
Table Industry Policy of Molecular Diagnostics in Cancer Testing
Table Industry News List of Molecular Diagnostics in Cancer Testing
Table Bill of Materials (BOM) of Molecular Diagnostics in Cancer Testing
Table Bill of Materials (BOM) Price of Molecular Diagnostics in Cancer Testing
Table Labor Cost of Molecular Diagnostics in Cancer Testing
Table Depreciation Cost of Molecular Diagnostics in Cancer Testing
Table Manufacturing Cost Structure Analysis of Molecular Diagnostics in Cancer Testing in 2015
Figure Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
Table European Price Analysis of Molecular Diagnostics in Cancer Testing 2011-2016 (USD/Unit)
Table European Cost Analysis of Molecular Diagnostics in Cancer Testing 2011-2016 (USD/Unit)
Table European Gross Analysis of Molecular Diagnostics in Cancer Testing 2011-2016
Table Capacity (K Units) and Commercial Production Date of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table Manufacturing Plants Distribution of European Key Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Table R&D Status and Technology Source of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table Raw Materials Sources Analysis of European and European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table European Production of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (K Units)
Table European Production Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table European Production of Molecular Diagnostics in Cancer Testing by Types in 2011-2016 (K Units)
Table European Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2011-2016
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2014
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015
Table European Sales of Molecular Diagnostics in Cancer Testing by Applications 2011-2016 (K Units)
Table European Production Market Share of Molecular Diagnostics in Cancer Testing by Applications 2011-2016
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2014
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2015
Table Price Comparison of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015 (USD/Unit)
Table European Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Molecular Diagnostics in Cancer Testing 2011-2016
Table European Consumption Volume of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (K Units)
Table European Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure European Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure European Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table European Consumption Value of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (M USD)
Table European Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure European Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure European Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table Consumption Price of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (USD/Unit)
Table European and Major Manufacturers Capacity of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table European Capacity Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table European and Major Manufacturers Production of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table European Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table European and Major Manufacturers Sales of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table European Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table European and Major Manufacturers Sales Revenue of Molecular Diagnostics in Cancer Testing 2011-2016 (M USD)
Table European Sales Revenue Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Figure European Capacity (K Units), Production (K Units) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure European Capacity Utilization Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure European Sales Revenue (M USD) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure European Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2014
Figure European Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Figure European Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2014
Figure European Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Figure European Sales (K Units) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Table European Supply, Consumption and Gap of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table European Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table Price of European Molecular Diagnostics in Cancer Testing Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of European Molecular Diagnostics in Cancer Testing Major Manufacturers 2011-2016
Table European and Major Manufacturers Revenue of Molecular Diagnostics in Cancer Testing 2011-2016 (M USD)
Table European Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Molecular Diagnostics in Cancer Testing 2011-2016
Table Abbott Molecular Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Abbott Molecular Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Abbott Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Abbott Molecular Diagnostics 2011-2016
Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Accugenomics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Accugenomics, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Accugenomics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Accugenomics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Accugenomics, Inc. 2011-2016
Table Accugenomics, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Agendia Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Agendia
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Agendia 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Agendia 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Agendia 2011-2016
Table Agendia Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Ambry Genetics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Ambry Genetics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ambry Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Ambry Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Ambry Genetics 2011-2016
Table Ambry Genetics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Biodesix Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Biodesix
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biodesix 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Biodesix 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Biodesix 2011-2016
Table Biodesix Molecular Diagnostics in Cancer Testing SWOT Analysis
Table bioMerieux Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of bioMerieux
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of bioMerieux 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of bioMerieux 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of bioMerieux 2011-2016
Table bioMerieux Molecular Diagnostics in Cancer Testing SWOT Analysis
Table bioTheranostics (AviaraDx) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of bioTheranostics (AviaraDx)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of bioTheranostics (AviaraDx) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of bioTheranostics (AviaraDx) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of bioTheranostics (AviaraDx) 2011-2016
Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Cancer Genetics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Cancer Genetics, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cancer Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Cancer Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Cancer Genetics, Inc. 2011-2016
Table Cancer Genetics, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Clarient, Inc. (GE Healthcare) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Clarient, Inc. (GE Healthcare)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Clarient, Inc. (GE Healthcare) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Clarient, Inc. (GE Healthcare) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Clarient, Inc. (GE Healthcare) 2011-2016
Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Counsyl Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Counsyl
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Counsyl 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Counsyl 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Counsyl 2011-2016
Table Counsyl Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Flatiron Health Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Flatiron Health
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Flatiron Health 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Flatiron Health 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Flatiron Health 2011-2016
Table Flatiron Health Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Epigenomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Epigenomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Epigenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Epigenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Epigenomics 2011-2016
Table Epigenomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Exact Sciences Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Exact Sciences Corporation
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exact Sciences Corporation 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Exact Sciences Corporation 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Exact Sciences Corporation 2011-2016
Table Exact Sciences Corporation Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Exiqon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Exiqon
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exiqon 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Exiqon 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Exiqon 2011-2016
Table Exiqon Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genomic Health, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genomic Health, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genomic Health, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genomic Health, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Genomic Health, Inc. 2011-2016
Table Genomic Health, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genoptix, Inc. (Novartis) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genoptix, Inc. (Novartis)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genoptix, Inc. (Novartis) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genoptix, Inc. (Novartis) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Genoptix, Inc. (Novartis) 2011-2016
Table Genoptix, Inc. (Novartis) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genmark Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genmark Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genmark Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genmark Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Genmark Diagnostics 2011-2016
Table Genmark Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genomictree Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genomictree
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genomictree 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genomictree 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Genomictree 2011-2016
Table Genomictree Molecular Diagnostics in Cancer Testing SWOT Analysis
Table HTG Molecular Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of HTG Molecular Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of HTG Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of HTG Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of HTG Molecular Diagnostics 2011-2016
Table HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Invitae Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Invitae
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Invitae 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Invitae 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Invitae 2011-2016
Table Invitae Molecular Diagnostics in Cancer Testing SWOT Analysis
Table LabCorp Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of LabCorp
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of LabCorp 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of LabCorp 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of LabCorp 2011-2016
Table LabCorp Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Myriad Genetics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Myriad Genetics, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Myriad Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Myriad Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Myriad Genetics, Inc. 2011-2016
Table Myriad Genetics, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Nanostring Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Nanostring
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nanostring 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Nanostring 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Nanostring 2011-2016
Table Nanostring Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Neogenomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Neogenomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Neogenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Neogenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Neogenomics 2011-2016
Table Neogenomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table NSTG Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of NSTG
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of NSTG 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of NSTG 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of NSTG 2011-2016
Table NSTG Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Nuvera Biosciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Nuvera Biosciences
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nuvera Biosciences 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Nuvera Biosciences 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Nuvera Biosciences 2011-2016
Table Nuvera Biosciences Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Orion Genomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Orion Genomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Orion Genomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Orion Genomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Orion Genomics 2011-2016
Table Orion Genomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Pathway Genomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Pathway Genomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pathway Genomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Pathway Genomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Pathway Genomics 2011-2016
Table Pathway Genomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Personal Genome Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Personal Genome Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Personal Genome Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Personal Genome Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Personal Genome Diagnostics 2011-2016
Table Personal Genome Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Quest Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Quest Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Quest Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Quest Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Quest Diagnostics 2011-2016
Table Quest Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Rosetta Genomics Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Rosetta Genomics Ltd.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Rosetta Genomics Ltd. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Rosetta Genomics Ltd. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Rosetta Genomics Ltd. 2011-2016
Table Rosetta Genomics Ltd. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Signal Genetics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Signal Genetics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Signal Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Signal Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Signal Genetics 2011-2016
Table Signal Genetics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Source MDx Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Source MDx
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Source MDx 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Source MDx 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Source MDx 2011-2016
Table Source MDx Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Wilex, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Wilex, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Wilex, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Wilex, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Wilex, Inc. 2011-2016
Table Wilex, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Molecular Diagnostics in Cancer Testing Price by Regions 2011-2016
Table Molecular Diagnostics in Cancer Testing Price by Product Types 2011-2016
Table Molecular Diagnostics in Cancer Testing Price by Companies 2011-2016
Table Molecular Diagnostics in Cancer Testing Gross Margin by Companies 2011-2016
Table Price Comparison of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (USD/Unit)
Table Price of Different Molecular Diagnostics in Cancer Testing Product Types (USD/Unit)
Table Market Share of Different Molecular Diagnostics in Cancer Testing Price Level
Table Gross Margin of Different Molecular Diagnostics in Cancer Testing Applications
Table Marketing Channels Status of Molecular Diagnostics in Cancer Testing
Table Traders or Distributors
Figure Picture of Molecular Diagnostics in Cancer Testing
Table Product Specifications of Molecular Diagnostics in Cancer Testing
Table Classification of Molecular Diagnostics in Cancer Testing
Figure European Sales Market Share of Molecular Diagnostics in Cancer Testing by Product Types in 2015
Table Applications of Molecular Diagnostics in Cancer Testing
Figure European Sales Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2015
Figure Industry Chain Structure of Molecular Diagnostics in Cancer Testing
Table European Industry Overview of Molecular Diagnostics in Cancer Testing
Table Industry Policy of Molecular Diagnostics in Cancer Testing
Table Industry News List of Molecular Diagnostics in Cancer Testing
Table Bill of Materials (BOM) of Molecular Diagnostics in Cancer Testing
Table Bill of Materials (BOM) Price of Molecular Diagnostics in Cancer Testing
Table Labor Cost of Molecular Diagnostics in Cancer Testing
Table Depreciation Cost of Molecular Diagnostics in Cancer Testing
Table Manufacturing Cost Structure Analysis of Molecular Diagnostics in Cancer Testing in 2015
Figure Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
Table European Price Analysis of Molecular Diagnostics in Cancer Testing 2011-2016 (USD/Unit)
Table European Cost Analysis of Molecular Diagnostics in Cancer Testing 2011-2016 (USD/Unit)
Table European Gross Analysis of Molecular Diagnostics in Cancer Testing 2011-2016
Table Capacity (K Units) and Commercial Production Date of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table Manufacturing Plants Distribution of European Key Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Table R&D Status and Technology Source of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table Raw Materials Sources Analysis of European and European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015
Table European Production of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (K Units)
Table European Production Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table European Production of Molecular Diagnostics in Cancer Testing by Types in 2011-2016 (K Units)
Table European Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2011-2016
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2014
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015
Table European Sales of Molecular Diagnostics in Cancer Testing by Applications 2011-2016 (K Units)
Table European Production Market Share of Molecular Diagnostics in Cancer Testing by Applications 2011-2016
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2014
Figure European Production Market Share of Molecular Diagnostics in Cancer Testing by Applications in 2015
Table Price Comparison of European Molecular Diagnostics in Cancer Testing Key Manufacturers in 2015 (USD/Unit)
Table European Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Molecular Diagnostics in Cancer Testing 2011-2016
Table European Consumption Volume of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (K Units)
Table European Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure European Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure European Consumption Volume Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table European Consumption Value of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (M USD)
Table European Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions 2011-2016
Figure European Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2014
Figure European Consumption Value Market Share of Molecular Diagnostics in Cancer Testing by Regions in 2015
Table Consumption Price of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (USD/Unit)
Table European and Major Manufacturers Capacity of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table European Capacity Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table European and Major Manufacturers Production of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table European Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table European and Major Manufacturers Sales of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table European Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Table European and Major Manufacturers Sales Revenue of Molecular Diagnostics in Cancer Testing 2011-2016 (M USD)
Table European Sales Revenue Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers 2011-2016
Figure European Capacity (K Units), Production (K Units) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure European Capacity Utilization Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure European Sales Revenue (M USD) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Figure European Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2014
Figure European Production Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Figure European Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2014
Figure European Sales Market Share of Major Molecular Diagnostics in Cancer Testing Manufacturers in 2015
Figure European Sales (K Units) and Growth Rate of Molecular Diagnostics in Cancer Testing 2011-2016
Table European Supply, Consumption and Gap of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table European Import, Export and Consumption of Molecular Diagnostics in Cancer Testing 2011-2016 (K Units)
Table Price of European Molecular Diagnostics in Cancer Testing Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of European Molecular Diagnostics in Cancer Testing Major Manufacturers 2011-2016
Table European and Major Manufacturers Revenue of Molecular Diagnostics in Cancer Testing 2011-2016 (M USD)
Table European Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Molecular Diagnostics in Cancer Testing 2011-2016
Table Abbott Molecular Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Abbott Molecular Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Abbott Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Abbott Molecular Diagnostics 2011-2016
Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Accugenomics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Accugenomics, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Accugenomics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Accugenomics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Accugenomics, Inc. 2011-2016
Table Accugenomics, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Agendia Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Agendia
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Agendia 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Agendia 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Agendia 2011-2016
Table Agendia Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Ambry Genetics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Ambry Genetics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ambry Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Ambry Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Ambry Genetics 2011-2016
Table Ambry Genetics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Biodesix Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Biodesix
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biodesix 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Biodesix 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Biodesix 2011-2016
Table Biodesix Molecular Diagnostics in Cancer Testing SWOT Analysis
Table bioMerieux Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of bioMerieux
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of bioMerieux 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of bioMerieux 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of bioMerieux 2011-2016
Table bioMerieux Molecular Diagnostics in Cancer Testing SWOT Analysis
Table bioTheranostics (AviaraDx) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of bioTheranostics (AviaraDx)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of bioTheranostics (AviaraDx) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of bioTheranostics (AviaraDx) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of bioTheranostics (AviaraDx) 2011-2016
Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Cancer Genetics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Cancer Genetics, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cancer Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Cancer Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Cancer Genetics, Inc. 2011-2016
Table Cancer Genetics, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Clarient, Inc. (GE Healthcare) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Clarient, Inc. (GE Healthcare)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Clarient, Inc. (GE Healthcare) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Clarient, Inc. (GE Healthcare) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Clarient, Inc. (GE Healthcare) 2011-2016
Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Counsyl Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Counsyl
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Counsyl 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Counsyl 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Counsyl 2011-2016
Table Counsyl Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Flatiron Health Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Flatiron Health
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Flatiron Health 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Flatiron Health 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Flatiron Health 2011-2016
Table Flatiron Health Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Epigenomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Epigenomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Epigenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Epigenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Epigenomics 2011-2016
Table Epigenomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Exact Sciences Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Exact Sciences Corporation
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exact Sciences Corporation 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Exact Sciences Corporation 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Exact Sciences Corporation 2011-2016
Table Exact Sciences Corporation Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Exiqon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Exiqon
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Exiqon 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Exiqon 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Exiqon 2011-2016
Table Exiqon Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genomic Health, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genomic Health, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genomic Health, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genomic Health, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Genomic Health, Inc. 2011-2016
Table Genomic Health, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genoptix, Inc. (Novartis) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genoptix, Inc. (Novartis)
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genoptix, Inc. (Novartis) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genoptix, Inc. (Novartis) 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Genoptix, Inc. (Novartis) 2011-2016
Table Genoptix, Inc. (Novartis) Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genmark Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genmark Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genmark Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genmark Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Genmark Diagnostics 2011-2016
Table Genmark Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Genomictree Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Genomictree
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genomictree 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Genomictree 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Genomictree 2011-2016
Table Genomictree Molecular Diagnostics in Cancer Testing SWOT Analysis
Table HTG Molecular Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of HTG Molecular Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of HTG Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of HTG Molecular Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of HTG Molecular Diagnostics 2011-2016
Table HTG Molecular Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Invitae Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Invitae
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Invitae 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Invitae 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Invitae 2011-2016
Table Invitae Molecular Diagnostics in Cancer Testing SWOT Analysis
Table LabCorp Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of LabCorp
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of LabCorp 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of LabCorp 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of LabCorp 2011-2016
Table LabCorp Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Myriad Genetics, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Myriad Genetics, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Myriad Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Myriad Genetics, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Myriad Genetics, Inc. 2011-2016
Table Myriad Genetics, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Nanostring Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Nanostring
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nanostring 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Nanostring 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Nanostring 2011-2016
Table Nanostring Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Neogenomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Neogenomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Neogenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Neogenomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Neogenomics 2011-2016
Table Neogenomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table NSTG Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of NSTG
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of NSTG 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of NSTG 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of NSTG 2011-2016
Table NSTG Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Nuvera Biosciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Nuvera Biosciences
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nuvera Biosciences 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Nuvera Biosciences 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Nuvera Biosciences 2011-2016
Table Nuvera Biosciences Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Orion Genomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Orion Genomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Orion Genomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Orion Genomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Orion Genomics 2011-2016
Table Orion Genomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Pathway Genomics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Pathway Genomics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pathway Genomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Pathway Genomics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Pathway Genomics 2011-2016
Table Pathway Genomics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Personal Genome Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Personal Genome Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Personal Genome Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Personal Genome Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Personal Genome Diagnostics 2011-2016
Table Personal Genome Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Quest Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Quest Diagnostics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Quest Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Quest Diagnostics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Quest Diagnostics 2011-2016
Table Quest Diagnostics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Rosetta Genomics Ltd. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Rosetta Genomics Ltd.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Rosetta Genomics Ltd. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Rosetta Genomics Ltd. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Rosetta Genomics Ltd. 2011-2016
Table Rosetta Genomics Ltd. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Signal Genetics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Signal Genetics
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Signal Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Signal Genetics 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Signal Genetics 2011-2016
Table Signal Genetics Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Source MDx Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Source MDx
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Source MDx 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Source MDx 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Source MDx 2011-2016
Table Source MDx Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Wilex, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Molecular Diagnostics in Cancer Testing Picture and Specifications of Wilex, Inc.
Table Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Wilex, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Capacity (K Units), Production (K Units) and Growth Rate of Wilex, Inc. 2011-2016
Figure Molecular Diagnostics in Cancer Testing Production (K Units) and European Market Share of Wilex, Inc. 2011-2016
Table Wilex, Inc. Molecular Diagnostics in Cancer Testing SWOT Analysis
Table Molecular Diagnostics in Cancer Testing Price by Regions 2011-2016
Table Molecular Diagnostics in Cancer Testing Price by Product Types 2011-2016
Table Molecular Diagnostics in Cancer Testing Price by Companies 2011-2016
Table Molecular Diagnostics in Cancer Testing Gross Margin by Companies 2011-2016
Table Price Comparison of Molecular Diagnostics in Cancer Testing by Regions 2011-2016 (USD/Unit)
Table Price of Different Molecular Diagnostics in Cancer Testing Product Types (USD/Unit)
Table Market Share of Different Molecular Diagnostics in Cancer Testing Price Level
Table Gross Margin of Different Molecular Diagnostics in Cancer Testing Applications
Table Marketing Channels Status of Molecular Diagnostics in Cancer Testing
Table Traders or Distributors
